Keyword: Johnson Matthey

Chemistry & Life Sciences

Chemspec Europe 2017 in Munich bigger than ever

24.05.2017 - Chemspec Europe 2017 is just around the corner: The 32nd edition of the International Exhibition for Fine and Speciality Chemicals takes place from 31 May – 1 June 2017 at the...

Chemistry & Life Sciences

Chemspec Europe 2017 Show Preview now available

12.05.2017 - Chemspec Europe 2017 is the International Exhibition for Fine and Speciality Chemicals. From 31 May – 1 June 2017, about 390 exhibitors from 29 countries will meet at the Munich...

News

Johnson Matthey Reorganizes Divisions

24.04.2017 - UK specialty chemical and technology group Johnson Matthey has announced it is reorganizing its corporate divisions with immediate effect. It has retained four divisions but some...

Chemistry & Life Sciences

Chemspec Europe 2017: Register now for the International Exhibition for Fine and Speciality Chemicals

12.04.2017 - Less than two months to go until the international experts of the fine and speciality chemicals industry meet in Munich. From 31 May – 1 June 2017, about 350 exhibitors from 24...

Chemistry & Life Sciences

Chemspec Europe 2017

17.03.2017 - Chemspec Europe, the International Exhibition for Fine and Speciality Chemicals, makes a return to Munich for its 32nd edition. From 31 May – 1 June 2017, manufacturers, suppliers...

News

ADM Licenses Glucaric Acid Technology

02.03.2017 - US food processing company Archer Daniels Midland (ADM) has signed an agreement to license bio-based glucaric acid technology from the UK’s Johnson Matthey and US bio-based...

Chemistry & Life Sciences

Johnson Matthey Launches New Online Catalyst Store

12.01.2017 - Johnson Matthey announced the launch of its new online catalyst store which, according to the company, provides customers with easy access to research quantities of commercial...

Research & Innovation

Experts Statements: Dr. Bernhard J. Paul, Johnson Matthey

12.12.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...